Seventy-five years of estimating the force of infection from current status data

Epidemiology and Infection

Volumn 138, Issue 6, 2010, Pages 802-812

  Hens, N ^a   Aerts, M ^a   Faes, C ^a   Shkedy, Z ^a   Lejeune, O ^b   Van Damme, P ^a   Beutels, P ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Hugo Muench; Incidence data; Infectious diseases; Serological data; Statistical modelling

Indexed keywords

AIRBORNE INFECTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH SURVEY; HISTORY OF MEDICINE; HUMAN; INFECTION PREVENTION; PARVOVIRUS INFECTION; RUBELLA; SERODIAGNOSIS; SEROPREVALENCE; VACCINATION; ADOLESCENT; ADULT; BIOLOGICAL MODEL; CHILD; COMMUNICABLE DISEASE; EPIDEMIC; HISTORY; HUMAN PARVOVIRUS B19; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DISEASE OUTBREAKS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, BIOLOGICAL; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RUBELLA; YOUNG ADULT;

EID: 77952513478     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990781     Document Type: Article

References (69)

1. Bernoulli D. An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it [in French]. Histoire et Mémoires de l'Académie des Sciences 1760; 2: 1-79.
2. Hamer WH. Epidemic disease in England. Lancet 1906; i : 733-739.
3. Brownlee J. Statistical studies in immunity: the theory of an epidemic. Proceedings Royal Society of Edinburgh 1906; 26: 484-521.
4. Ross R. The Prevention of Malaria. London: John Murray 1911.
5. Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics. Proceedings of the Royal Society of London, Series A 1927; 115: 700-721.
6. Muench H. Derivation of rates from summation data by the catalytic curve. Journal of the American Statistical Association 1934; 29: 25-38.
7. Muench H. Catalytic Models in Epidemiology. Harvard University Press : Boston, 1959.
8. Collins SD. Age incidence of the common communicable diseases of children. Public Health Reports 1929; 44: 14.
9. Farrington CP, Kanaan MN, Gay NJ. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Journal of the Royal Statistical Society, Series C 2001; 50: 251-292.
10. Hens N, et al. Modelling multi-sera data: the estimation of new joint and conditional epidemiological parameters. Statistics in Medicine 2008; 27: 2651-2664.
11. Griffiths D. A catalytic model of infection for measles. Journal of the Royal Statistical Society, Series C 1974; 23: 330-339.
12. Gay NJ. A model of long-term decline in the transmissibility of an infectious disease : implications for the incidence of hepatitis A. International Journal of Epidemiology 1996; 25: 854-861.
13. Schenzle D, Dietz K, Frösner GG. Antibody against hepatitis A in seven European countries. Statistical analysis of cross-sectional surveys. American Journal of Epidemiology 1979; 110: 70-76.
14. Anderson RM, May RM. Directly transmitted infectious diseases : control by vaccination. Science 1982; 215: 1053-1060.
15. Grenfell BT, Anderson RM. The estimation of agerelated rates of infection from case notifications and serological data. Journal of Hygiene 1985; 95: 19-36.
16. Farrington CP. Modeling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953-967.
17. Massad E, Raimundo SM, Silveira ASB. A continuous function model for the age-related force of infection. Mathematical and Computer Modelling 1990; 13: 101-112.
18. McCullagh P, Nelder JA. Generalized Linear Models. Chapman & Hall, 1989.
19. Keiding N, et al. Estimation from current status data in continuous time. Lifetime Data Analysis 1996; 2: 119-129.
20. Shkedy Z, et al. Modeling age dependent force of infection from prevalence data using fractional polynomials. Statistics in Medicine 2006; 5: 1577-1591.
21. Hens N, et al. Modelling distortions in seroprevalence data using change-point fractional polynomials. Statistical Modelling (in press).
22. Hens N, et al. Handling missingness when modelling the force of infection from clustered seroprevalence data. Journal of Agricultural, Biological and Environmental Statistics 2007; 12: 1-16.
23. Faes C, et al. Population-averaged versus herd-specific force of infection. Journal of the Royal Statistical Society, Series C 2006; 55: 595-613.
24. Van Effelterre T, et al. Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus. Epidemiology and Infection 2009; 137: 48-57.
25. Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866-7872.
26. Nardone A, Miller E. Serological surveillance of rubella in Europe: European sero-epidemiology network (ESEN2). Eurosurveillance 2004; 9: 5-7.
27. Edmunds WJ, Pebody RG, Aggerback HEA. The seroepidemiology of diphtheria in Western Europe. European sero-epidemiology network (ESEN). Epidemiology and Infection 2000; 125: 113-125.
28. Edmunds WJ, et al. The prevaccination epidemiology of measles, mumps and rubella in Europe: implications for modeling studies. Epidemiology and Infection 2000; 125: 635-650.
29. Beutels P, et al. Hepatitis B in St Petersburg, Russia (1994-1999): incidence, prevalence and force of infection. Journal of Viral Hepatitis 2003; 10: 141-149.
30. Keiding N. Age-specific incidence and prevalence : a statistical perspective (with discussion). Journal of the Royal Statistical Society, Series A 1991; 154: 371-412.
31. Nagelkerke N, et al. Semi-parametric estimation of agetime specific infection incidence from serial prevalence data. Statistics in Medicine 1999; 18: 307-320.
32. Shkedy Z, et al. Modelling forces of infection by using monotone local polynomials. Journal of the Royal Statistical Society, Series C 2003; 52: 469-485.
33. Greenhalgh D, Dietz K. Some bounds on estimates for reproductive ratios derived from the age-specific force of infection. Mathematical Biosciences 1994; 12: 49-57.
34. Shiboski SC. Generalized additive models for current status data. Lifetime Data Analysis 1998; 4: 29-50.
35. Hastie TJ, Tibshirani RJ. Generalized additive models: some applications. Journal of the American Statistical Association 1987; 82: 371-386.
36. Hastie TJ, Tibshirani RJ. Generalized Additive Models. New York: Chapman and Hall, 1990.
37. Namata H, et al. Estimation of the force of infection from current status data using generalized linear mixed models. Journal of Applied Statistics 2007; 34: 923-939.
38. van Boven M, et al. Waninig immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Mathematical Biosciences 2000; 164: 161-182.
39. Coen PG, et al. Mathematical models of Haemophilus influenzae type B. Epidemiology and Infection 1998; 120: 281-295.
40. Fine PEM, Clarkson JA. Measles in England and Wales - I : an analysis of factors underlying seasonal patterns. International Journal Epidemiology 1982; 11: 5-14.
41. Grassly NC, Fraser C. Seasonal infectious disease epidemiology. Proceedings of the Royal Society of London, Series B 2006; 273, 2541-2550.
42. Zaaijer HL, Koppelman MH, Farrington CP. Parvovirus B19 viraemia in Dutch blood donors. Epidemiology and Infection 2004; 132: 1161-1166.
43. Whitaker HJ, Farrington CP. Estimation of infectious disease parameters from serological survey data: the impact of regular epidemics. Statistics in Medicine 2004; 23: 2429-2443.
44. Mathei C, et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatitis 2006; 13: 560-570.
45. Sutherland I, Svandova E, Radhakrishna SE. The development of clinical tuberculosis following infection with tubercle bacilli. Tubercle 1982; 62: 255-269.
46. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Advances in Tuberculosis Research 1976; 19: 1-63.
47. Vynnycky E and Fine PEM. The natural history of tuberculosis : the implications of age-dependent risks of disease and the role of re-infection. Epidemiology and Infection 1997; 119: 183-201.
48. Becker NG. Analysis of Infectious Diseases Data. London: Chapman and Hall, 1989.
49. Hens N, et al. Estimating the impact of vaccination using age-time-dependent incidence rates of hepatitis B. Epidemiology and Infection 2008; 136: 341-351.
50. Amaku M, et al. Vaccination against rubella : analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns. Physical Review E 2003; 67: 5.
51. Zhang YX. A compound catalytic model with both reversible and two-stage types and its applications in epidemiological study. International Journal of Epidemiology 1987; 16: 619-621.
52. Beutels P, et al. Hepatitis B in St Petersburg, Russia (1994-1999): incidence, prevalence and force of infection. Journal of Viral Hepatitis 2003; 10: 141-149.
53. Morris MC, et al. Sero-epidemiological patterns of Epstein-Barr and herpes simplex (HSV-1 and HSV-2) viruses in England and Wales. Journal of Medical Virology 2002; 67: 522-527.
54. Nardone A, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866-7872.
55. Shkedy Z, et al. Modeling age dependent force of infection from prevalence data using fractional polynomials. Statistics in Medicine 2006; 5: 1577-1591.
56. Thiry N, et al. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). European Journal of Pediatrics 2002; 161: 588-593.
57. Whitaker HJ, Farrington CP. Infections with varying contact rates : application to varicella. Biometrics 2004; 60: 615-623.
58. Ades AE, Nokes DJ. Modeling age- and timespecific incidence from seroprevalence : toxoplasmosis. American Journal of Epidemiology 1993; 137: 1022-1034.
59. Mossong J, et al. Parvovirus B19 infection in five European countries : seroepidemiology, force of infection and maternal risk of infection. Epidemiology and Infection 2008; 136: 1059-1068.
60. Gay NJ. Analysis of serological surveys using mixture models: application to a survey of parvovirus B19. Statistics in Medicine 1996; 15: 1567-1573.
61. Bollaerts K, et al. Estimating the force of infection directly from antibody levels. Statistics in Medicine (in press).
62. Kanaan MN, Farrington CP. Matrix models for childhood infections : a Bayesian approach with applications to rubella and mumps. Epidemiology and Infection 2005; 133: 1009-1021.
63. Coutinho FAB, et al. Modelling heterogeneities in individual frailties in epidemic models. Mathematical and Computer Modelling 1999; 30: 97-115.
64. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991.
65. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiology 2006; 164: 936-944.
66. Ogunjimi B, et al. Using empirical social contact data to model person to person infectious disease transmission : an illustration for varicella. Mathematical Biosciences 2009; 278: 80-87.
67. Goeyvaerts N, et al. Estimating transmission parameters and the basic reproduction number using social contact data and serological data on varicella zoster virus in Belgium. Journal of the Royal Statistical Society, Series C (in press).
68. Hens N, et al. Modeling Infectious Disease Parameters Based on Serological and Social Contact Data:AModern Statistical Perspective. New York: Springer-Verlag (in press).
69. Wilson EB, Worcester J. Contact with measles. Proceedings of the National Academy of Sciences USA 1941; 27: 7-13.